You are here: Industry Insights > china

News List

Eisai to market anti-Obesity agent in China through CY Biotech biospectrumasia
August 01, 2018
Eisai will receive a one-time contractual payment and milestone payments dependent upon acquisition of regulatory approval. In addition, Eisai has the option rights to co-promote lorcaserin with CYB in China
China investors lead financing round for Omniome biospectrumasia
July 31, 2018
A portion of the proceeds from the financing will be used to expand the company's capabilities by hiring new team members across multiple disciplines.
Solasia Pharma announces approval of Sancusco in China biospectrumasia
July 30, 2018
Sancuso is the world’s first and only transdermal patch of the 5-HT3 receptor antagonist used for the prevention of nausea and vomiting in patients receiving chemotherapy regimens
Zecotek Reforms to align Technology, IP and Business biospectrumasia
July 25, 2018
Zecotek Imaging China, a subsidiary of Zecotek Imaging Systems (Singapore), is commercializing patented LFS scintillation crystals through its new crystal production facility in Shanghai, China
An Overview of the Mental Disorder Field in China W&D
July 25, 2018
Mental disorder refers to the varying degrees of disorder of cognition, emotion, behavior and will, etc. caused by disorder of brain functional activity.
Changchun Changsheng Life Sciences to stop output after drug safety scandal biospectrumasia
July 24, 2018
The CFDA has asked the provincial food and drug administration of Jilin, where the company is based, to revoke Changchun Changsheng’s Good Manufacturing Practice (GMP) certificate, an international recognized license for drug production.
Chance for global vaccine makers? China’s latest vaccine scandal sparks fury and fear fiercepharma
July 24, 2018
The bad news: China’s latest vaccine scandal, with its second-largest rabies vaccine maker at front and center, went berserk on social media over the weekend.
CEO Weber sees China as Takeda’s second-largest business—in the long run: report fiercepharma
July 19, 2018
Takeda CEO Christophe Weber has a big ambition for its China business: to make the country its second most important market. But it’s a huge task that could take a long time to achieve—if it happens at all.
China opens market to Indian drugs with reduced tariffs pharmafile
July 17, 2018
India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most populous countries.
Merck inks deal with China's Xian Janssen for type 2 diabetes drug biospectrumasia
July 16, 2018
China has more than 114 million people living with diabetes, the largest number of any country in the world

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page